Fusion Finance Ltd

Certificate receipt

• Certificate under Reg 74(5) received from registrar to issue and transfer agent.
• Copy of the certificate available on the company website.

ESOP allotment details

• 10,00,000 equity shares allotted to Fusion Employees Benefit Trust.
• Face value Rs 10 per share; fully paid-up.
• Under Fusion Employee Stock Option Plan 2023.
• Date of allotment: September 28, 2026.
• ISIN: INE139R01012.
• Total post-issue shares: 16,30,82,277; paid-up capital: Rs 162,91,92,490.
• All shares rank pari-passu with existing shares.
• Lock-in: Not applicable.
• Listing fees to be paid at listing; in-principal approvals obtained.

Interest payment on NCDs

• Interest payment on NCD ISIN INE139R07456 made for Sep 2026.
• Issue size INR 150 crore; monthly payment; record date 14 Sep 2026.
• Interest due: INR 13.95 crore; actual paid: INR 12.555 crore post-tax.
• Payment date: 28 Sep 2026; due date 29 Sep 2026; no delay.
• Redemption payments: NIL; no redemption activity.
• Frequency of interest payments: monthly.

Cessation: Chief Strategy Officer

• Priyanka Wadhera resigns as Chief Strategy Officer, effective Sept 25, 2026; last day Dec 19, 2026; pursuing opportunities.
• Resignation noted by Nomination and Remuneration Committee and Board; no interim arrangements disclosed.

Fusion Finance Ltd — Trading Window closed from Oct 1, 2026 till the end of 48 hours after the declaration of Un-Audited Financial Results for the quarter and half year ending on September 30, 2026.

Meeting Details

• Date: September 29, 2026; time not disclosed.
• Type/Mode: One-to-One and group meetings; in-person, Mumbai.
• Event: Analysts/Institutional Investors Meeting organized by Fusion Finance.
• Key participants: Company management to attend; no personal names provided.
• Purpose: investor interaction with management; no unpublished price information to be shared.

ESOP grant details

• Approved grant of 94,600 ESOPs to eligible employees under ESOP 2023.
• Exercise price set at INR 188.18 per option (NSE close Sep 15, 2026).
• Options vest not before one year from grant date; vesting per ESOP 2023.
• Exercise period eight years from vesting date.
• Total options under ESOP 2023: 94,600 shares.
• Scheme complies with SEBI SBEB Regulations 2021.
• NRC approved in meeting on Sep 15, 2026.
• Options exercised: Not applicable to date.

HR leadership changes

• Ms. Pooja Mehta resigns as CHRO and Senior Managerial Personnel, effective Sept 15, 2026.
• Her last working day will be Oct 11, 2026.
• Ms. Chinmayi Trivedi appointed CHRO and Senior Managerial Personnel, effective Sept 15, 2026.
• Appointment approved based on NRC recommendation.
• Ms. Trivedi is not related to any Director or KMP.
• Ms. Trivedi brings 20+ years of HR leadership experience.

Transfer of stressed loan portfolio

• Board approved and executed sale on September 7, 2026.
• Stressed loan portfolio outstanding value ₹54.16 crore as of 30 June 2026.
• Sale consideration ₹35.20 crore to Asset Reconstruction Company under RBI Master Directions 2025.
• Bilateral sale under RBI Master Directions 2025 for credit risk transfer.
• Disclosure under SEBI LODR Regulation 30.

Trading approval details

• Trading approvals granted for 2,27,856 partly paid shares converted to fully paid; trading begins Sep 4, 2026.
• Shares rank pari-passu with existing equity shares.
• Rights Issue First Call money payments were offered per June 17, 2026 notice.